Use of Fibryga, a Fibrinogen Concentrate in Real World: Retrospective Collection of Clinical Data

Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency

NCT02408484 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

NCT01410227 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap

NCT01575756 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

NCT03695978 ·Status: RECRUITING

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A

NCT00989196 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness and Tolerability of Eqwilate in Real-life Conditions

NCT04106908 ·Status: ACTIVE_NOT_RECRUITING

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

NCT00851721 ·Status: COMPLETED ·Phase: PHASE3

Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia

NCT01285089 ·Status: COMPLETED

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

NCT05936580 ·Status: RECRUITING ·Phase: PHASE4

Drug Use Investigation of Kovaltry in Hemophilia A Patients

NCT02941783 ·Status: COMPLETED

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

NCT01913405 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery

NCT00092976 ·Status: COMPLETED ·Phase: PHASE4

Low VW Activity in Adolescent HMB

NCT02933411 ·Status: ACTIVE_NOT_RECRUITING

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A

NCT01178294 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B

NCT04286412 ·Status: COMPLETED ·Phase: PHASE4

An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency

NCT02427217 ·Status: COMPLETED

Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

NCT00426803 ·Status: COMPLETED ·Phase: PHASE2

A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care

NCT02049099 ·Status: COMPLETED

Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment

NCT04053699 ·Status: COMPLETED

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A

NCT01434511 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

NCT02141074 ·Status: COMPLETED ·Phase: PHASE3

Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A

NCT02610127 ·Status: COMPLETED

Clinical and Health-related Outcome of rFVIIIFc Prophylaxis

NCT04583930 ·Status: UNKNOWN

Treatment of Inherited Factor VII Deficiency

NCT01269138 ·Status: COMPLETED

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

NCT01125813 ·Status: COMPLETED ·Phase: PHASE3